[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.66.254. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1975

Management of Parathyroid Glands in Surgery for Medullary Thyroid Carcinoma

Author Affiliations

From the departments of surgery (Dr. Block) and medicine (Dr. Jackson), Henry Ford Hospital, Detroit, and the Laboratory of Pharmacology, Harvard School of Dental Medicine and the Department of Pharmacology, Harvard Medical School, Boston (Dr. Tashjian).

Arch Surg. 1975;110(5):617-624. doi:10.1001/archsurg.1975.01360110163027
Abstract

Of 13 patients treated surgically for familial medullary thyroid carcinoma in whom parathyroid tissue was available, the majority showed parathyroid abnormalities (hyperplasia in six, tumors in five). Two patients had had renal calculi. No correlation was evident between the presence of the parathyroid tumors and peripheral blood levels of parathyroid hormone. Hyperparathyroidism is usually mild, but occasionally it results in complications of hypercalcemia. Hyperparathyroidism has not appeared to date following removal of medullary thyroid carcinoma associated with normal-sized but microscopically hyperplastic parathyroids. Evidence of parathyroid abnormalities has not been recognized in eight patients with sporadic medullary carcinoma, making genetic factors dominant in explaining the association of parathyroid hyperplasia and this carcinoma. At operation, parathyroid glands should be evaluated and those that are grossly enlarged removed while preserving parathyroid function.

×